{"version":"1.0","type":"link","title":"Clinical characteristics, management, and prognosis of pembrolizumab-induced immune-related oral mucositis.","author_name":"Yu L 외","author_url":"https://prs-insight.online/author/Yu%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168767","thumbnail_width":1200,"thumbnail_height":630}